TECENTRIQ™ Metastatic Urothelial Carcinoma Treatment

- bladder-cancer-therapy.com

Learn about TECENTRIQ™ (atezolizumab) for metastatic urothelial carcinoma (mUC) treatment, TECENTRIQ financial support, patient resources, and more. mUC Patient Indication and Safety Information What is TECENTRIQ? TECENTRIQ is a prescription medicine used to treat: • A type of bladder cancer called urothelial carcinoma

Not Applicable $ 8.95


ATEZOLIZUMAB | ROCHE

- rochesafetytool.com

ROCHE provides information for healthcare professionals who are prescribing Atezolizumab

Not Applicable $ 8.95